4570 — Immuno-Biological Laboratories Co Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Immuno-Biological Laboratories Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -250 | -281 | 125 | 210 | 301 |
| Depreciation | |||||
| Non-Cash Items | 134 | 349 | -7.84 | 2.9 | -10 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 22.5 | 11 | 14.6 | -44.7 | -7.98 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -93.2 | 79.7 | 134 | 183 | 301 |
| Capital Expenditures | — | — | -18.7 | -59.7 | -33.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -156 | 30 | -5.84 | 6 | -83 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -156 | 30 | -24.5 | -53.7 | -116 |
| Financing Cash Flow Items | — | -0.001 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 144 | 0.991 | 0.992 | -31.8 | -27.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -103 | 113 | 113 | 95.6 | 158 |